The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Serial next generation sequencing (NGS) of cell free DNA (cfDNA) and clonal evolution of AKT1 E17K mutant tumors: Analyses from patients (pts) enrolled on a phase I basket study of an AKT inhibitor (AZD5363).
 
Lillian Mary Smyth
Consulting or Advisory Role - AstraZeneca
 
Jonathan B Reichel
No Relationships to Disclose
 
Jiabin Tang
No Relationships to Disclose
 
Juber Ahamad A Patel
No Relationships to Disclose
 
Fanli Meng
No Relationships to Disclose
 
S Duygu Selcuklu
No Relationships to Disclose
 
Daoqi You
No Relationships to Disclose
 
Aliaksandra Samoila
No Relationships to Disclose
 
Gaia Schiavon
No Relationships to Disclose
 
Bob T. Li
Consulting or Advisory Role - Biosceptre International; Roche
 
Pedram Razavi
No Relationships to Disclose
 
Salvatore Piscuoglio
No Relationships to Disclose
 
Jorge S. Reis-Filho
No Relationships to Disclose
 
Clifford A. Hudis
Other Relationship - Breast Cancer Research Foundation
 
Jose Baselga
No Relationships to Disclose
 
David B. Solit
Honoraria - Loxo; Novartis; Pfizer
Consulting or Advisory Role - Loxo; Pfizer
 
Barry S. Taylor
No Relationships to Disclose
 
David Michael Hyman
Consulting or Advisory Role - Atara Biotherapeutics; Chugai Pharma
Research Funding - AstraZeneca; Puma Biotechnology
Travel, Accommodations, Expenses - AstraZeneca; Puma Biotechnology
 
Michael F. Berger
Consulting or Advisory Role - Cancer Genetics; Sequenom
 
Sarat Chandarlapaty
Honoraria - Bayer; Chugai Pharma; Daiichi Sankyo; GlaxoSmithKline; Oncothyreon; Takeda
Research Funding - Lilly (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Bayer; GlaxoSmithKline; Takeda